NEWS 8 FEED & ADDITIVE MAGAZINE July 2024 dsm-firmenich, innovators in nutrition, health and beauty, announced an agreement to sell its yeast extract business to Lesaffre, a key global player in fermentation and micro-organisms. Yeast extracts is part of dsm-firmenich's taste, texture & health business unit, with annual sales of about €120 million. As part of dsm-firmenich's tuning of its portfolio, the company de-prioritized certain business segments. The divestment from yeast extracts is an outcome of that strategic review process, which was announced on June 3. As part of the transaction, Lesaffre will enter into an agreement to supply yeast extracts to dsm-firmenich for its Savory business. In addition, dsm-firmenich and Lesaffre will enter a technology partnership for the development of yeast extracts. After the completion of the deal, dsm-firmenich will continue to supply yeast extracts produced in Delft to Lesaffre until the end of 2025, after which point the yeast extracts production in Delft will be discontinued. Lesaffre will ensure uninterrupted supply to yeast extracts customers and provide them with the same service levels and innovation support as today. Also, as part of the deal, some of the dsm-firmenich employees working on yeast extracts will transfer to Lesaffre. Read more>> Purdue University will partner with Elanco Animal Health and become part of Indiana’s new One Health Innovation District. The announcement was made at Indiana’s 2024 Global Economic Summit after Purdue President Mung Chiang and Elanco President and CEO Jeff Simmons signed a shared Memorandum of Understanding with the Indiana Economic Development Corp. to establish a globally recognized research innovation district dedicated to optimizing the health of people, animals, plants and the planet. Purdue and Elanco have committed to develop a new shared-use facility on 3 acres in the One Health Innovation District near the future Elanco global headquarters on the western edge of the White River in Indianapolis, US. The facility is designed to deliver and scale up innovation where industry and academia can collaborate including office, wet lab and incubator space. This is in addition to the nearly complete 220,000-square-foot corporate headquarters of Elanco Animal Health, with an expected opening date in the second quarter of 2025. Elanco also announced its commitment to purchase an additional 12 acres to the north of its existing footprint for future expansion and the development of the Epicenter for Animal Health. “Totality of Purdue to the totality of Indianapolis — that’s our pledge as the Indianapolis part of Purdue’s main campus officially launches on July 1,” said Chiang, Purdue President. “In the coming years, all programs at Purdue will find homes throughout our state’s capital city. Today’s announcement carries a special excitement for the partnership and the location. Purdue is excited to partner with Elanco and other collaborators to build out the ecosystem of One Health Innovation District, starting from the building announced and expanding to an entire district. Human health, animal health, plant health will be jointly advanced by the nation’s leading companies and our state’s top-ranked university.” Read more>> dsm-firmenich sells its yeast extract business to Lesaffre Purdue and Elanco partner for new innovation district
RkJQdWJsaXNoZXIy MTUxNjkxNQ==